Zdrowie i gospodarka · 12/02/2016

FDA Classifies Scalp Cooling System for Chemotherapy-Induced Alopecia into Class II with Special Controls

The FDA is classifying the scalp cooling system to reduce chemotherapy-induced alopecia into Class II with special controls, aiming to ensure the device's safety and effectiveness.